Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma | Gut

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

XML

Hepatology

Original research

Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma

Online download statistics by month:

Online download statistics by month: March 2020 to May 2023

	Abstract	Full	Pdf
Mar 2020	330	321	99
Apr 2020	404	382	215
May 2020	199	193	93
Jun 2020	154	146	92
Jul 2020	116	112	66
Aug 2020	95	91	48
Sep 2020	131	124	99
Oct 2020	115	108	78
Nov 2020	139	127	71
Dec 2020	549	539	169
Jan 2021	249	226	137
Feb 2021	206	176	138
Mar 2021	148	133	117
Apr 2021	148	134	105
May 2021	153	129	173
Jun 2021	110	105	146
Jul 2021	170	159	135
Aug 2021	126	119	104
Sep 2021	121	110	94
Oct 2021	180	168	146
Nov 2021	178	167	121
Dec 2021	157	166	87
Jan 2022	260	251	142
Feb 2022	177	174	101
Mar 2022	239	246	102
Apr 2022	220	225	117
May 2022	141	142	98
Jun 2022	168	164	102
Jul 2022	176	168	73
Aug 2022	129	135	72
Sep 2022	96	91	94
Oct 2022	119	110	46
Nov 2022	141	132	73
Dec 2022	99	85	35
Jan 2023	72	60	51
Feb 2023	119	102	37
Mar 2023	69	66	40
Apr 2023	71	66	43
May 2023	82	64	50
Total	6556	6216	3809